PDF) The EPIPHA-KNEE trial: Explaining Pain to target unhelpful pain beliefs to Increase PHysical Activity in KNEE osteoarthritis – a protocol for a multicentre, randomised controlled trial with clinical- and cost- effectiveness analysis
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models - The Lancet Global Health
Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease | SpringerLink
Covid-19 testing data can help schools stay open this year - STAT
People in Economics: Data-Driven in: Finance & Development Volume 0058 Issue 004 (2021)
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease - Kidney International
Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease | SpringerLink
Nobel Prize-winning Class of 1991 Ph.D. alumnus returns to Brown to discuss research in causal relationships | Brown University
2019 Scientific Program - 2019 - Journal of Ultrasound in Medicine - Wiley Online Library
Surveillance, screening, and self-testing can help us manage COVID in the long term - The Boston Globe
Better health projections lead to better health policy, says new SHP faculty member - FSI
PDF) Problems with evidence assessment in COVID-19 health policy impact evaluation: a systematic review of study design and evidence strength
Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis - The Lancet Global Health
A guide for the diagnosis of rare and undiagnosed disease: beyond the exome | Genome Medicine | Full Text
Joshua Salomon – Prevention Policy Modeling Lab
Program | INTERSPEECH 2021
Jeremy D. Goldhaber-Fiebert's 235 research works in Biology and Medicine
FSI | SHP - Joshua Salomon
An open repository of real-time COVID-19 indicators | PNAS
Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease | SpringerLink
FSI | SHP - Health Policy News
Joshua Salomon – MIDAS
FSI | SHP - Joshua Salomon
